Wright Medical reported a total net income of $2.4 million, up from a loss of $2.4 million in the same period last year.
According to the release, net sales increased 0.4 percent over 2008 to reach $118.9 million in the second quarter of 2009. Global sales of the company’s extremity product line increased 17 percent, but Wright Medical reported hip, knee and biologic product sales decreasing by 1 percent, 3 percent and 6 percent, respectively, in the second quarter of 2009.
Domestically, Wright Medical saw a 24 percent increase in its extremity line and a 2 percent increase in its hip product line, according to the release. The biologic line remained flat and knee sales declined 1 percent.
Internationally, sales were down 7 percent compared with 2008.
As a result, Wright Medical has revised its 2009 sales guidance to a range of $475-$485 million as opposed to the previous goal of $500-$510 million, according to the release.
Read the release about Wright Medical’s second quarter results (pdf).
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
